CASE REPORT
Accepted on 23 Dec 2024
Brigatinib Treatment in a Patient with Advanced NSCLC with XPO1-ALK Fusion: A Case Report
doi 10.3389/fonc.2024.1503262
- Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
- Research Topics
- Adapting Drug Repurposing to Drug Resistance in Cancer Volume II: Developing Synergistic Combinations
Adapting Drug Repurposing to Drug Resistance in Cancer Volume II: Developing Synergistic Combinations
642
Total downloads
3,265
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CASE REPORT
Published on 11 Dec 2024
Long-term follow-up of combination therapy with pembrolizumab and anlotinib in thoracic SMARCA4-deficient undifferentiated tumor: a case report and molecular features
doi 10.3389/fonc.2024.1453895
- 333 views
REVIEW
Accepted on 31 Oct 2024
Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line -An Expert Opinion
doi 10.3389/fonc.2024.1502185
REVIEW
Published on 15 May 2024
Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy
doi 10.3389/fcell.2024.1369597
- 1,899 views
- 2 citations
Published in
Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.
Impact
- 3,265Topic views
- 2,151Article views
- 642Article downloads